A Novel Validated Method for the Determination of Dapoxetine HCl by RP-HPLC in Bulk and Tablet Dosage Forms

Author(s): Mehdi Rezaei, Ali Ramazani*

Journal Name: Current Pharmaceutical Analysis

Volume 14 , Issue 6 , 2018

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Background: The purpose of this study is the development and validation of assay test for Dapoxetine Hydrochloride in the pharmaceutical dosage forms by HPLC. The assay method by HPLC was found to be linear in the concentration range of 25 to 150 µg/mL. The mobile phase was composed of methanol and buffer pH: 7.0 ammonium dihydrogen phosphate (80:20 v/v) at the flow rate of 1 mL/min using UV detection at 232 nm.

Results and Conclusion: The analytical results were validated by recovery studies. The percentage recovery method was found to be 99.58-100.75%. The LOD and LOQ were found to 0.008 µg/mL and 0.027 µg/mL. All the parameters of validation were in the acceptance range. This developed method was successfully applied to estimate the amount of Dapoxetine Hydrochloride in the tablets.

Keywords: Dapoxetine hydrochloride, RP-HPLC, pharmaceutical, validation, analysis, buffer solution, robustness.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 16 September, 2018
Page: [622 - 626]
Pages: 5
DOI: 10.2174/1573412913666171115162602
Price: $65

Article Metrics

PDF: 18
PRC: 1